ARCA Biopharma Inc (ABIO)

2.070 -0.030 (-1.43%)
Closed USD Disclaimer

ABIO Financial Summary

ARCA biopharma, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 1.35 million compared to USD 3.27 million a year ago. Basic loss per share from continuing operations was USD 0.09 compared to USD 0.23 a year ago. Diluted loss per share from continuing operations was USD 0.09 compared to USD 0.23 a year ago.
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
ABIO
Gross margin TTM -
Operating margin TTM 0%
Net Profit margin TTM 0%
Return on Investment TTM -15.8%
Total Revenue
Net Income
Title
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Total Revenue
Gross Profit
Operating Income -1.64 -1.58 -1.76 -3.22
Net Income -1.35 -1.17 -2.33 -3.15
Clear All
0Selected
Please try another search
ABIO
Quick Ratio MRQ 32.27
Current Ratio MRQ 32.94
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 0.88%
Total Assets
Total Liabilities
Title
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Total Assets 42.06 43.08 44.96 48.10
Total Liabilities 1.53 1.41 2.24 3.14
Total Equity 40.53 41.67 42.73 44.96
Clear All
0Selected
Please try another search
ABIO
Cash Flow/Share TTM -0.57
Revenue/Share TTM -
Operating Cash Flow -125.98%
Cash
Net Change in Cash
Title
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Cash From Operating Activities -1.60 -1.49 -2.50 -2.62
Cash From Investing Activities 0 0 0
Cash From Financing Activities
Net Change in Cash -1.60 -1.49 -2.50 -2.62
Clear All
0Selected
Please try another search

* In Millions of (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.